• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acids

Research Brief on 2-Cyano-4-methylbenzoic Acid (CAS: 1195306-28-5) in Chemical Biology and Pharmaceutical Applications

2-Cyano-4-methylbenzoic acid (CAS: 1195306-28-5) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in pharmaceutical development and chemical biology. This compound, characterized by its cyano and carboxylic acid functional groups, serves as a critical building block in the synthesis of more complex molecules. Recent studies have explored its utility in drug discovery, particularly in the design of kinase inhibitors and other small-molecule therapeutics. The unique structural features of 2-cyano-4-methylbenzoic acid make it an attractive candidate for medicinal chemistry applications, offering opportunities for structural modifications to enhance bioactivity and pharmacokinetic properties.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the role of 2-cyano-4-methylbenzoic acid as a precursor in the synthesis of novel EGFR (epidermal growth factor receptor) inhibitors. The study highlighted the compound's ability to form stable interactions with key amino acid residues in the ATP-binding pocket of EGFR, thereby inhibiting its activity. The researchers employed molecular docking and in vitro assays to validate the inhibitory effects of derivatives synthesized from 2-cyano-4-methylbenzoic acid. These findings suggest its potential as a scaffold for developing targeted cancer therapies, particularly for non-small cell lung cancer (NSCLC) and other EGFR-driven malignancies.

Another notable application of 2-cyano-4-methylbenzoic acid was reported in a 2022 ACS Chemical Biology article, where it was utilized as a key intermediate in the synthesis of fluorescent probes for imaging cellular processes. The cyano group in the compound was functionalized to introduce fluorophores, enabling real-time visualization of enzymatic activity in live cells. This approach has significant implications for studying disease mechanisms and screening potential drug candidates. The study demonstrated the compound's compatibility with bioorthogonal chemistry, further expanding its utility in chemical biology research.

Recent advancements in synthetic methodologies have also improved the accessibility of 2-cyano-4-methylbenzoic acid. A 2023 Organic Process Research & Development paper described a scalable and cost-effective synthesis route using palladium-catalyzed cyanation of 4-methylbenzoic acid derivatives. This innovation addresses previous challenges related to yield and purity, making the compound more readily available for industrial and academic research. The optimized protocol achieved a >90% yield with high purity, facilitating its broader adoption in drug discovery programs.

In conclusion, 2-cyano-4-methylbenzoic acid (CAS: 1195306-28-5) continues to emerge as a valuable tool in chemical biology and pharmaceutical research. Its applications span from drug design to cellular imaging, supported by recent studies that underscore its versatility and potential. Future research may explore additional derivatives and their therapeutic efficacy, further solidifying its role in advancing medicinal chemistry and biomedical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)